Skip to content
healthcare.dev
Get a free key

Quinapril and Hydrochlorothiazide 20/25

NDC 69097-831, Quinapril and Hydrochlorothiazide 20/25, tablet, from Cipla USA Inc..

Product NDC
69097-831
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA201356
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-831 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • QUINAPRIL HYDROCHLORIDE20 mg/1
  • HYDROCHLOROTHIAZIDE25 mg/1

Pharmacologic classes

Angiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]

Package NDCNDC-11Package
69097-831-056909708310590 TABLET in 1 BOTTLE (69097-831-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1de5420c-23d6-40c5-ba24-39143c0f90fb

Use it

Look up 69097-831 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-831 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-831. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.